ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 49 filers reported holding ALPINE IMMUNE SCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $75,000 | -98.4% | 7,001 | -98.7% | 0.00% | -98.3% |
Q2 2021 | $4,704,000 | -40.1% | 522,635 | -29.5% | 0.18% | -49.6% |
Q1 2021 | $7,858,000 | -15.9% | 741,290 | 0.0% | 0.35% | -30.5% |
Q4 2020 | $9,340,000 | +43.3% | 741,290 | 0.0% | 0.50% | +8.0% |
Q3 2020 | $6,516,000 | – | 741,290 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 2,571,450 | $17,640,000 | 4.25% |
BVF INC/IL | 1,201,717 | $8,244,000 | 0.92% |
Orbimed Advisors | 3,670,955 | $25,183,000 | 0.39% |
TIGER MANAGEMENT L.L.C. | 137,728 | $945,000 | 0.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 475,450 | $3,262,000 | 0.12% |
Hikari Power Ltd | 122,972 | $844,000 | 0.09% |
ALPINE WOODS CAPITAL INVESTORS, LLC | 15,000 | $103,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 35,750 | $245,000 | 0.00% |
DRW Securities, LLC | 10,000 | $69,000 | 0.00% |
VICTORY CAPITAL MANAGEMENT INC | 134,542 | $923,000 | 0.00% |